Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"

NCT01935466 · clinicaltrials.gov ↗

COMPLETED

Status

6107

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Pioglitazone

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh